Aiming for an Epigenetics Edge, Chroma Raises $135M to Move Closer to the Clinic
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading